Used in biochemical research as a triple reuptake inhibitor targeting dopamine, norepinephrine, and serotonin, particularly in the central nervous system, this compound serves as an intermediate in the synthesis of pharmaceuticals for central nervous system disorders. It is studied to evaluate potential in treating depression, anxiety, and mood regulation issues. Its structure facilitates effective blood-brain barrier penetration for direct brain action. Valuable in laboratory studies of neurochemical pathways involving monoamine transporters and for developing analogs of antidepressants and cognitive-enhancing drugs. Applications are confined to laboratory and preclinical research settings.